Trademark Overview
On Tuesday, August 25, 2009, a trademark application was filed for OKIOSE with the United States Patent and Trademark Office. The USPTO has given the OKIOSE trademark a serial number of 77811835. The federal status of this trademark filing is ABANDONED - EXPRESS as of Wednesday, September 23, 2009. This trademark is owned by Pfizer Inc.. The OKIOSE trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, inflammation, HIV/AIDS, and Alzheimer's disease; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines
